Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Fig. 5

Cancer associated genes upon FAK inhibition. A Heatmap representation of the expression of up-regulated (A) and down-regulated (B) cancer-related genes in HepG2 and Huh7 cells in TAE226 > SOR compared to NT cells. C Venn diagrams showing the overlapping of up-regulated (upper circles) and down-regulated (lower circles) genes in HepG2 and Huh7 cells treated with TAE226 > SOR compared to NT cells. D Bar plots of the 10 most abundant pathways for commonly up-regulated (upper plot) or down-regulated (lower plot) genes in both HCC cells after treatment with TAE226 > SOR

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us